WMA Declaration of Helsinki – Ethical Principles f... ...
A Professional Overview of Hypertension ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
A Professional Overview of Hypertension ...
Ask the Heart Doctor | Heart Valve Disease and Sur...
How humble cells in a little-known organ manage brain inflam...
September 09,2024 0
Warning Signs of PTSD...
August 26,2024 0
Do you believe that a good friend is a relative of your choi...
December 13,2024 0
Feet first: AI reveals how infants connect with their world...
October 09,2024 0
​The Surprising World of Olympic Nutrition...
August 22,2024 0
Survey indicates sugar and carbohydrate claims affect consum...
December 31,2024 0
Category
Oncology
Cardiology & Vascular Surgery
Gastroenterology
Pediatrics
Hematology&Oncology
Ophthalmology
Medicine
Plastic Surgery
Medical research
Sleep
Most Read
Study finds bone injections don't improve survival over IV in cardiac arrest treatment

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
Cardiovascular Diseases November 27,2024 0
Study finds bone injections don't improve survival over IV in cardiac arrest treatment

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
Cardiovascular Diseases November 27,2024 0
Science-2024 Breakthrough of the Year：The long shot

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Medicial Breakthroughs December 13,2024 0
Science-2024 Breakthrough of the Year：The long shot

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Medicial Breakthroughs December 13,2024 0
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Why MDMA did NOT get FDA approval...
Reprogramming Stem Cells Could Cure Type...
Can a twice-a-year shot help end the HIV...
Dr. Fauci among hundreds who've contract...
More News
In rats, intrauterine exposure to cannabinoid affects cardiorespiratory function and sleep quality in adulthood

In rats, intrauterine exposure to cannabinoid affects cardiorespiratory function and sleep quality in adulthood

by André Julião,FAPESPMales and females exhibited different cardiorespiratory and sleep quality outcomes after being exposed to a synthetic cannabinoid in the womb. Credit: illustration: Luis Gu
Cardiovascular Diseases October 21,2024 0
In rats, intrauterine exposure to cannabinoid affects cardiorespiratory function and sleep quality in adulthood

In rats, intrauterine exposure to cannabinoid affects cardiorespiratory function and sleep quality in adulthood

by André Julião,FAPESPMales and females exhibited different cardiorespiratory and sleep quality outcomes after being exposed to a synthetic cannabinoid in the womb. Credit: illustration: Luis Gu
Cardiovascular Diseases October 21,2024 0
Potential therapy target for cardiac arrhythmias found in SK2 channels

Potential therapy target for cardiac arrhythmias found in SK2 channels

byUniversity of ArizonaCredit: Unsplash/CC0 Public DomainA new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identif
Cardiovascular Diseases October 21,2024 0
Potential therapy target for cardiac arrhythmias found in SK2 channels

Potential therapy target for cardiac arrhythmias found in SK2 channels

byUniversity of ArizonaCredit: Unsplash/CC0 Public DomainA new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identif
Cardiovascular Diseases October 21,2024 0
Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

byUniversity at BuffaloCredit: Andrea Piacquadio from PexelsA small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and
Public Health & Prevention October 21,2024 0
Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

byUniversity at BuffaloCredit: Andrea Piacquadio from PexelsA small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and
Public Health & Prevention October 21,2024 0
Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi
Oncology October 21,2024 0
Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi
Oncology October 21,2024 0
Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

by Julia Moióli,FAPESPThe figure shows the interaction between the synthetic ACE2 peptide (yellow) and the SARS-CoV-2 spike protein. The spikes of the original viral strain from Wuhan and the om
Public Health & Prevention October 21,2024 0
Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

by Julia Moióli,FAPESPThe figure shows the interaction between the synthetic ACE2 peptide (yellow) and the SARS-CoV-2 spike protein. The spikes of the original viral strain from Wuhan and the om
Public Health & Prevention October 21,2024 0
Precision breast cancer trial shows improved treatment by tumor subtype

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea
Oncology October 21,2024 0
Precision breast cancer trial shows improved treatment by tumor subtype

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea
Oncology October 21,2024 0
Clinical trial finds new drug significantly extends lives of breast cancer patients

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa
Oncology October 21,2024 0
Clinical trial finds new drug significantly extends lives of breast cancer patients

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa
Oncology October 21,2024 0
Experts release the latest guide for systematic reviews of preclinical research

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud
Medical research October 21,2024 0
Experts release the latest guide for systematic reviews of preclinical research

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud
Medical research October 21,2024 0
Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

byUniversity of TurkuChange in back pain intensity on a scale from 0 to 10. The blue bars represent individuals in the intervention group that reduced sitting and the red bars represent the cont
Orthopedics & Sports medicine October 21,2024 0
Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

byUniversity of TurkuChange in back pain intensity on a scale from 0 to 10. The blue bars represent individuals in the intervention group that reduced sitting and the red bars represent the cont
Orthopedics & Sports medicine October 21,2024 0
Event-free survival extended with long-term finerenone in heart failure

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief
Cardiovascular Diseases October 21,2024 0
Event-free survival extended with long-term finerenone in heart failure

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief
Cardiovascular Diseases October 21,2024 0
More News
Week’s Top
Podcasts
... Breakthrough in Brain-Machine Interface: Chinese “Thought Communication” Becomes Reality Compared to decoding English’s 26 letters, decoding Chinese with its “418 syllables and 4 tones” presents a higher difficulty. ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Health spending has been rising across rich countries with different systems ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
APP
Medicine.net
Meditionary
PanWriting
PanDraw